Cargando…

Emerging clinical role of ranolazine in the management of angina

Chronic stable angina is an exceedingly prevalent condition with tremendous clinical, social, and financial implications. Traditional medical therapy for angina consists of beta-blockers, calcium channel blockers, and nitrates. These agents decrease myocardial oxygen demand and ischemia by reducing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vadnais, David S, Wenger, Nanette K
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963161/ https://www.ncbi.nlm.nih.gov/pubmed/21063462 http://dx.doi.org/10.2147/TCRM.S4468

Ejemplares similares

Update on ranolazine in the management of angina
por: Codolosa, J Nicolás, et al.
Publicado: (2014)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Utility of ranolazine in chronic stable angina patients
por: Patel, Pawan D, et al.
Publicado: (2008)

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris
por: Aldakkak, Mohammed, et al.
Publicado: (2013)

Extended-release ranolazine: critical evaluation of its use in stable angina
por: Truffa, Adriano AM, et al.
Publicado: (2011)

The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization
por: Calcagno, Simone, et al.
Publicado: (2020)

Ranolazine Reduces Patient-Reported Angina Severity and Frequency and Improves Quality of Life in Selected Patients with Chronic Angina
por: Muhlestein, Joseph B., et al.
Publicado: (2013)

Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris
por: Chaturvedi, Aditi, et al.
Publicado: (2013)

Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective
por: Coleman, Craig I, et al.
Publicado: (2015)

Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study
por: Kourlaba, Georgia, et al.
Publicado: (2015)

Improvement of Subjective Well-Being by Ranolazine in Patients with Chronic Angina and Known Myocardial Ischemia (IMWELL Study)
por: Bavry, Anthony A., et al.
Publicado: (2017)

Ranolazine: A Contemporary Review
por: Rayner‐Hartley, Erin, et al.
Publicado: (2016)

Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning
por: Rouhana, Sarah, et al.
Publicado: (2021)

Erratum to: Improvement of Subjective Well-Being by Ranolazine in Patients with Chronic Angina and Known Myocardial Ischemia (IMWELL Study)
por: Bavry, Anthony A., et al.
Publicado: (2017)

Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria – the ARETHA AT study
por: Zweiker, Robert, et al.
Publicado: (2019)

Resolution of Angina Pectoris and Improvement of the Coronary Flow Reserve after Ranolazine Treatment in a Woman with Isolated Impaired Coronary Microcirculation
por: Santoro, Alessandro, et al.
Publicado: (2013)

Ranolazine Toxicity Secondary to Paxlovid
por: Casey, Bradley, et al.
Publicado: (2023)

Mechanism of action of the new anti-ischemia drug ranolazine
por: Hasenfuss, G., et al.
Publicado: (2007)

Impact of ranolazine on ventricular arrhythmias – A systematic review
por: Bazoukis, George, et al.
Publicado: (2018)

Ranolazine: Multifaceted Role beyond Coronary Artery Disease, a Recent Perspective
por: Ghosh, Gopal Chandra, et al.
Publicado: (2018)

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
por: Bairey Merz, C. Noel, et al.
Publicado: (2016)

Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation
por: Verrier, Richard L., et al.
Publicado: (2013)

Hypertension management in older adults
por: Bilen, Ozlem, et al.
Publicado: (2020)

A Rare Neurological Complication of Ranolazine
por: Porhomayon, Jahan, et al.
Publicado: (2013)

Renal phospholipidosis possibly induced by ranolazine
por: Scheurle, Christoph, et al.
Publicado: (2014)

Improvement of Vascular Insulin Sensitivity by Ranolazine
por: Guerra-Ojeda, Sol, et al.
Publicado: (2023)

Antianginal Efficacy and Tolerability of Ranolazine as an Add-on Drug to Concomitant Medications Primarily Metoprolol in Chronic Stable Angina Patients: A Prospective, Open-Label Study
por: Khot, Anant Mahaveer, et al.
Publicado: (2017)

The Management of Angina Pectoris
por: Fox, Kim
Publicado: (1988)

Refractory atrial fibrillation effectively treated with ranolazine
por: Vaishnav, Aditi, et al.
Publicado: (2014)

Effects of Ranolazine on Astrocytes and Neurons in Primary Culture
por: Aldasoro, Martin, et al.
Publicado: (2016)

Keratolysis exfoliativa-like eruption induced by ranolazine
por: Pierobon, Elena, et al.
Publicado: (2022)

The Role of Ivabradine in the Management of Angina Pectoris
por: Giavarini, Alessandra, et al.
Publicado: (2016)

The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation
por: Murdock, David K, et al.
Publicado: (2008)

Anti-adrenergic effects of ranolazine in isolated rat aorta
por: Marchio, P, et al.
Publicado: (2014)

Ranolazine can markedly increase tacrolimus blood levels
por: Seck, Sidy, et al.
Publicado: (2011)

COVID-19-related arrhythmias and the possible effects of ranolazine
por: Chukwunyere, Ugochukwu, et al.
Publicado: (2021)

Ranolazine - could an antianginal drug be used in stroke prevention?
por: Surma, Stanisław, et al.
Publicado: (2022)

Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture
por: Jordá, Adrián, et al.
Publicado: (2022)

Effect of anti-inflammatory activity of ranolazine in rat model of inflammation
por: Naveena, R., et al.
Publicado: (2018)

Role of ivabradine in management of stable angina in patients with different clinical profiles
por: Kaski, Juan Carlos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j0bj78qm2qbuv3js9uqg8sfpqs